AIC
ANIP icon

Ameritas Investment Company’s ANI Pharmaceuticals ANIP Stock Holding History

Ameritas Investment Company’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-41
Closed -$2K – 395
2020
Q1 		$2K Buy
+41
New +$2.18K ﹤0.01% 1546
2019
Q4 		– Sell
-41
Closed -$3K – 870
2019
Q3 		$3K Buy
+41
New +$3.07K ﹤0.01% 1362
2019
Q1 		– Sell
-96
Closed -$4K – 982
2018
Q4 		$4K Buy
+96
New +$5.03K ﹤0.01% 1259

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameritas Investment Company's ANIP Position: Q2 2020 in Review

Ameritas Investment Company sold out of ANI Pharmaceuticals (ANIP) in Q2 2020, closing a stake of 41 shares — an estimated $2K sold.

Ameritas Investment Company first reported a position in ANIP in Q4 2018 and held it in 3 quarters. The position peaked at $4K in Q4 2018. 134 funds tracked by Wall St. Rank hold ANIP as of Q2 2020.

  • Ameritas Investment Company reported no remaining ANI Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Ameritas Investment Company sold 41 ANI Pharmaceuticals shares in Q2 2020, an estimated $2K.
  • Ameritas Investment Company first reported a position in ANI Pharmaceuticals in Q4 2018 and held it in 3 quarters.
  • Ameritas Investment Company's ANI Pharmaceuticals position peaked at $4K in Q4 2018.
  • 134 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2020.

Based on Ameritas Investment Company's 13F filing for Q2 2020, filed 14 Aug 2020.